Propafenone--a new agent for the treatment of ventricular arrhythmias.
Over the last several years a number of new and potent antiarrhythmic agents have been developed. One of these promising new drugs, propafenone hydrochloride (Rhythmol), will soon be available for use in this country. Although similar in some aspects to flecainide and encainide, the drug possesses some unique characteristics. The purpose of this review is to summarize the pharmacologic and physiologic effects of propafenone and to outline its clinical use.
Grubb
B P
BP
Department of Medicine, Medical College of Ohio, Toledo 43699.
D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006801:Humans; D011405:Propafenone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000188:drug therapy
D011405:Propafenone